全体要約
この市場で最も成長が期待されるセグメントはディープラーニングで、機械学習における重要な手法です。また、機能別に見ると、最大のシェアを占めるのはゲノム配列解析で、染色体障害や単一遺伝子障害などを特定するためにAIソリューションが活用されています。地域別では、北米が45%のシェアを持ち、続いて欧州が30%を占めています。主要企業にはNVIDIA、Microsoft、Googleなどが含まれます。
関連する質問
0.5 billion USD (2023)
32.3% (2023-2028)
NVIDIA Corporation, Microsoft Corporation, Google, Inc., Intel Corporation, BenevolentAI, SOPHiA GENETICS, Illumina, Inc., Predictive Oncology, Inc., Invitae Corporation, Deep Genomics, Inc., Fabric Genomics, Inc., Verge Genomics, Freenome Holdings, Inc., MolecularMatch, Inc., Dante labs, Data4Cure, PrecisionLife Ltd, Genoox, Lifebit, FDNA, Inc., DNAnexus, Engine Biosciences, Tempus Labs, Inc., Congenica Ltd, Emedgene, Inc., Seragon Pharmaceuticals, Inc.
プロセスとタイムラインの加速, 医薬品開発と発見のコスト削減, AIソリューションによる染色体障害の特定
概要
ディープラーニング：機械学習における人工知能（AI）のゲノミクス市場で最も急成長しているセグメント。
ディープラーニングセグメントは、予測期間中に感染監視サービス市場で最も速い成長を遂げると予想されています。ディープラーニング手法は、ゲノムにおける計算モデル戦略を支配しており、DNA配列からのタンパク質結合の理解、エピジェネティック修飾、エピジェネティックマークからの遺伝子発現の予測、あるいは単一細胞のメチル化状態の予測など、さまざまな質問に対処するために使用されています。加速されたゲノムシーケンシング分析ワークフローの需要の高まりと遺伝子編集ツールの機能を向上させる必要性が、市場の成長を促進することが期待されています。
「ゲノム配列決定セグメントは、予測期間中に機能別で最も大きな人工知能（AI）によるゲノミクス市場になると予想されています。」
機能に基づいて、市場はゲノムシーケンシング、遺伝子編集、臨床ワークフロー、および予測的遺伝子検査と予防医療に分かれています。ゲノムシーケンシング部門は、ゲノミクス市場における人工知能（AI）の最大のシェアを占めています。この部門の大きなシェアは、AIソリューションを使用して染色体障害、奇形症候群、催奇形性障害、および単一遺伝子障害を特定することに起因しています。
「ヨーロッパは予測期間中にゲノミクスにおける人工知能（AI）市場で第二の大きなシェアを占めました。」
ヨーロッパは、予測期間中にゲノミクス市場の人工知能（AI）の第二の大きなシェアを占めました。市場成長の主要な推進要因は、ゲノム研究や薬剤発見におけるAIベースツールの採用の増加、好意的な政府の取り組み、EMRの導入の増加、患者データのボリュームの増加、ベンチャーキャピタルの資金提供の増加、医療支出の増加、および高齢者人口の増加です。さらに、R&D活動を進展させるためのAIの可能性もこの分野への関心を引き寄せています。
主な参加者の内訳は以下の通りです：
・企業タイプ別 - Tier 1–40%、Tier 2–35%、Tier 3–25%
• 職位別 - Cクラス - 35%、ディレクタークラス - 25%、その他 - 40%
地域別 - 北米 45%、ヨーロッパ 30%、アジア太平洋 20%、およびその他の地域 5%
ゲノミクス市場における人工知能（AI）の主要プレーヤー
人工知能（AI）におけるゲノミクス市場で活動している主要な企業には、NVIDIA Corporation（アメリカ）、Microsoft Corporation（アメリカ）、Google, Inc.（アメリカ）、Intel Corporation（アメリカ）、BenevolentAI（イギリス）、SOPHiA GENETICS（スイス）、Illumina, Inc.（アメリカ）、Predictive Oncology, Inc.（アメリカ）、Invitae Corporation（アメリカ）、Deep Genomics, Inc.（カナダ）、Fabric Genomics, Inc.（アメリカ）、Verge Genomics（アメリカ）、Freenome Holdings, Inc.（アメリカ）、MolecularMatch, Inc.（アメリカ）、Dante labs（アメリカ）、Data4Cure（アメリカ）、PrecisionLife Ltd（イギリス）、Genoox（アメリカ）、Lifebit（イギリス）、FDNA, Inc.（アメリカ）、DNAnexus（アメリカ）、Engine Biosciences（アメリカ）、Tempus Labs, Inc.（アメリカ）、Congenica Ltd（イングランド）、Emedgene, Inc.（アメリカ）、およびSeragon Pharmaceuticals, Inc.（アメリカ）が含まれます。
調査範囲：
このレポートは、ゲノミクスにおける人工知能（AI）市場を分析し、提供、技術、機能、アプリケーション、最終ユーザー、地域などのさまざまなセグメントに基づいて、マーケットサイズと将来の成長ポテンシャルを推定することを目的としています。また、マーケットで入手可能なさまざまなゲノミクス製品とサービスの製品ポートフォリオマトリックスも含まれています。このレポートは、主要プレイヤーの競争分析とともに、企業プロフィール、製品提供、および主要市場戦略を提供します。
レポートを購入する理由
この報告書は、既存の企業と新規参入者・小規模企業の両方が市場の動向を把握するのに役立ち、それにより市場のより大きなシェアを獲得するのに貢献します。報告書を購入する企業は、市場での地位を強化するために以下に挙げる戦略のいずれかまたは複数を使用することができます。
この報告書は次のポイントに関する洞察を提供します：
• マーケット浸透：グローバルな人工知能（AI）ゲノミクス市場における主要企業が提供する製品ポートフォリオに関する包括的な情報です。この報告書は、製品とサービス、およびエンドユーザーによってこの市場を分析しています。
• 製品の強化/革新: 世界の人工知能（AI）におけるゲノミクス市場の今後のトレンドと製品発売に関する詳細な洞察
市場開発：製品とサービスおよび最終ユーザーによる有望な新興市場に関する包括的な情報
• マーケットの多様化：新製品や製品の強化、成長している地域、最近の動向、およびグローバルな人工知能（AI）におけるゲノミクス市場への投資に関する詳細情報
• 競争評価：グローバルな人工知能（AI）によるゲノム市場における主要企業の市場シェア、成長戦略、製品提供、競争リーダーシップのマッピング、能力に関する詳細な評価です。
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 イントロダクション 32
1.1 調査の目的 32
1.2 市場の定義 32
1.3 包含・除外事項 33
1.4 調査範囲 34
1.4.1 対象市場 34
1.4.2 対象地域 34
1.5 対象年 35
1.6 通貨 36
1.7 制約 36
1.8 ステークホルダー 37
1.9 変化のサマリー 37
2 調査手法 39
2.1 リサーチデータ 39
2.1.1 二次調査 42
- 2.1.1.1 二次情報の主要データ 43
2.1.2 一次調査 43
- 2.1.2.1 主要な一次ソース 44
- 2.1.2.2 一次情報の主要データ 45
- 2.1.2.3 業界についての主な考察 45
- 2.1.2.4 一次インタビュー内訳 46
2.2 市場規模予測 46
2.3 市場の内訳とデータのトライアンギュレーション 52
2.4 調査の前提 54
2.5 不況の影響 55
2.6 リスク評価 55
2.7 調査上の制約 56
3 エグゼクティブサマリー 57
4 更なる考察 62
4.1 ゲノミクス向け人工知能（AI）市場におけるプレーヤーの魅力的な機会 62
4.2 ゲノミクス向け人工知能（AI）市場：地域別 63
4.3 北米のゲノミクス向け人工知能（AI）市場：エンドユーザー・国別、2022年 64
4.4 ゲノミクス向け人工知能（AI）市場：提供製品別 65
4.5 ゲノミクス向け人工知能（AI）市場：技術別 65
4.6 ゲノミクス向け人工知能（AI）市場：エンドユーザー別 66
4.7 ゲノミクス向け人工知能（AI）市場：機能別 66
4.8 ゲノミクス向け人工知能（AI）市場：用途別 67
5 市場概要 68
5.1 イントロダクション 68
5.2 市場力学 68
5.2.1 促進要因 69
5.2.2 抑制要因 72
5.2.3 市場機会 72
- 5.2.3.1 人間を意識したAIシステムの開発に注力 72
5.2.4 課題 73
- 5.2.4.1 キュレーションされたゲノムデータの欠如 73
- 5.2.4.2 データプライバシー懸念 73
5.3 エコシステム分析 74
6 ゲノミクス向け人工知能（AI）市場：提供製品別 75
6.1 イントロダクション 76
6.2 ソフトウェア 77
6.2.1 標準的な統計手法によるエラーを削減するインテリジェント・ソフトウェア 77
6.3 サービス 78
7 ゲノミクス向け人工知能（AI）市場：技術別 80
7.1 イントロダクション 81
7.2 機械学習 82
7.2.1 ディープラーニング 84
7.2.2 教師あり学習 86
- 7.2.2.1 集団健康管理のための予測モデル作成に役立つ 86
7.2.3 強化学習 87
7.2.4 教師なし学習 89
7.2.5 その他の機械学習技術 90
7.3 その他の技術 91
8 ゲノミクス向け人工知能（AI）市場：機能別 93
8.1 イントロダクション 94
8.2 ゲノムシーケンス 95
8.3 遺伝子編集 96
8.4 臨床ワークフロー 98
8.4.1 臨床ワークフローの効率化に貢献 98
8.5 予測遺伝子検査と予防医学 99
9 ゲノミクス向け人工知能（AI）市場：用途別 101
9.1 イントロダクション 102
9.2 診断 103
9.3 ドラッグディスカバリー＆デベロップメント 105
9.4 精密医療 107
9.5 農業・動物研究分野 109
9.5.1 作物・家畜の生産性向上に役立つゲノムAI 109
9.6 その他の用途 111
10 ゲノミクス向け人工知能（AI）市場：エンドユーザー別 113
10.1 イントロダクション 114
10.2 製薬会社・バイオテクノロジー企業 115
10.3 研究センター、学術機関、政府機関 117
10.4 病院・医療機関 118
10.5 その他のエンドユーザー 120
11 ゲノミクス向け人工知能（AI）市場：地域別 122
11.1 イントロダクション 123
11.2 北米 124
11.2.1 北米：リセッション時のインパクト 124
11.2.2 米国 128
11.2.3 カナダ 132
- 11.2.3.1 ゲノミクス研究の進展が市場を牽引 132
11.3 ヨーロッパ 135
11.3.1 ヨーロッパ：リセッション時のインパクト 135
11.3.2 英国 138
11.3.3 ドイツ 142
- 11.3.3.1 AIイニシアチブのための資金供給が市場を押し上げる 142
11.3.4 フランス 145
- 11.3.4.1 NGSへの政府投資の増加が市場を押し上げる 145
11.3.5 その他ヨーロッパ 148
11.4 アジア太平洋 151
11.4.1 アジア太平洋：リセッション時のインパクト 152
11.5 その他地域 156
11.5.1 その他地域：リセッション時のインパクト 157
12 競合情勢 161
12.1 概要 161
12.2 KEY MARKET PLAYERS’ STRATEGIES/RIGHT TO WIN 161
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS, 2022 164
12.4 MARKET RANKING ANALYSIS, 2022 164
12.5 競合ベンチマーキング 167
12.6 主要プレーヤーの企業評価クアドラント 171
12.6.1 STARS 171
12.6.2 PERVASIVE PLAYERS 171
12.6.3 EMERGING LEADERS 171
12.6.4 PARTICIPANTS 171
12.7 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES 173
12.7.1 PROGRESSIVE COMPANIES 173
12.7.2 DYNAMIC COMPANIES 173
12.7.3 RESPONSIVE COMPANIES 173
12.7.4 STARTING BLOCKS 173
12.8 競合他社のシナリオと動向 175
12.8.1 製品の発売・強化 175
12.8.2 ディール 176
12.8.3 その他の展開 178
13 企業プロファイル 179
13.1 主要企業 179
13.1.1 NVIDIA CORPORATION 179
13.1.2 MICROSOFT CORPORATION 184
13.1.3 GOOGLE, INC 189
13.1.4 INTEL CORPORATION 193
13.1.5 BENEVOLENTAI 198
13.1.6 SOPHIA GENETICS 201
13.1.7 ILLUMINA, INC 205
13.1.8 PREDICTIVE ONCOLOGY, INC 210
13.1.9 INVITAE CORPORATION 213
13.1.10 DEEP GENOMICS, INC 216
13.1.11 FABRIC GENOMICS, INC 218
13.1.12 VERGE GENOMICS 220
13.1.13 FREENOME HOLDINGS, INC 222
13.1.14 MOLECULARMATCH, INC 224
13.1.15 DANTE LABS 225
13.1.16 DATA4CURE 228
13.1.17 PRECISIONLIFE LTD 229
13.1.18 GENOOX 231
13.1.19 LIFEBIT 233
13.2 OTHER EMERGING PLAYERS 236
13.2.1 Fdna社 236
13.2.2 DNAネクサス 236
13.2.3 エンジン・バイオサイエンス 237
13.2.4 テンポスラボ 237
13.2.5 コンジェニカ 238
13.2.6 エメドジーン社 238
13.2.7 セラゴン・ファーマシューティカルズ・インク 239
14 付録 240
14.1 ディスカッションガイド 240
14.2 ナレッジストアMarketsandmarketsの定期購読ポータルサイト 245
14.3 カスタマイズオプション 247
14.4 関連レポート 248
14.5 執筆者の詳細 249
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
Table of Contents
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.3 INCLUSIONS AND EXCLUSIONS 33
1.4 STUDY SCOPE 34
1.4.1 MARKETS COVERED 34
1.4.2 REGIONS COVERED 34
1.5 YEARS CONSIDERED 35
1.6 CURRENCY CONSIDERED 36
1.7 LIMITATIONS 36
1.8 STAKEHOLDERS 37
1.9 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
2.1.1 SECONDARY RESEARCH 42
- 2.1.1.1 Key data from secondary sources 43
2.1.2 PRIMARY RESEARCH 43
- 2.1.2.1 Key primary sources 44
- 2.1.2.2 Key data from primary sources 45
- 2.1.2.3 Key industry insights 45
- 2.1.2.4 Breakdown of primary interviews 46
2.2 MARKET SIZE ESTIMATION 46
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 52
2.4 RESEARCH ASSUMPTIONS 54
2.5 IMPACT OF RECESSION 55
2.6 RISK ASSESSMENT 55
2.7 RESEARCH LIMITATIONS 56
3 EXECUTIVE SUMMARY 57
4 PREMIUM INSIGHTS 62
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET 62
4.2 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION 63
4.3 NORTH AMERICAN ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER AND COUNTRY, 2022 64
4.4 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING 65
4.5 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY 65
4.6 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER 66
4.7 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY 66
4.8 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION 67
5 MARKET OVERVIEW 68
5.1 INTRODUCTION 68
5.2 MARKET DYNAMICS 68
5.2.1 DRIVERS 69
- 5.2.1.1 Need to accelerate processes and timeline and reduce drug development & discovery costs 69
- 5.2.1.2 Increased partnerships and collaborations among players and growing investments in AI in genomics 69
- 5.2.1.3 Rising adoption of AI in precision medicine 70
- 5.2.1.4 Explosion in bioinformatics data and genomic datasets 70
- 5.2.1.5 Improving computing power and declining hardware cost 71
5.2.2 RESTRAINTS 72
- 5.2.2.1 Lack of skilled AI workforce and ambiguous regulatory guidelines for medical software 72
5.2.3 OPPORTUNITIES 72
- 5.2.3.1 Focus on developing human-aware AI systems 72
5.2.4 CHALLENGES 73
- 5.2.4.1 Lack of curated genomic data 73
- 5.2.4.2 Data privacy concerns 73
5.3 ECOSYSTEM ANALYSIS 74
6 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING 75
6.1 INTRODUCTION 76
6.2 SOFTWARE 77
6.2.1 INTELLIGENT SOFTWARE TO REDUCE ERRORS CAUSED BY STANDARD STATISTICAL APPROACHES 77
6.3 SERVICES 78
6.3.1 RISING AI TECHNOLOGY ADOPTION IN VARIOUS END-USE INDUSTRIES TO BOOST MARKET 78
7 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY 80
7.1 INTRODUCTION 81
7.2 MACHINE LEARNING 82
7.2.1 DEEP LEARNING 84
- 7.2.1.1 Growing demand for accelerated genome sequencing analysis workflows and improved function of gene editing tools to propel market 84
7.2.2 SUPERVISED LEARNING 86
- 7.2.2.1 To help create predictive models for population health management 86
7.2.3 REINFORCEMENT LEARNING 87
- 7.2.3.1 Need to reduce costs associated with collecting labeled training data to drive segment 87
7.2.4 UNSUPERVISED LEARNING 89
- 7.2.4.1 Ability to perform more complex processing tasks than supervised learning systems to drive market 89
7.2.5 OTHER MACHINE LEARNING TECHNOLOGIES 90
7.3 OTHER TECHNOLOGIES 91
8 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY 93
8.1 INTRODUCTION 94
8.2 GENOME SEQUENCING 95
8.2.1 INCREASING ADOPTION OF MACHINE AND DEEP LEARNING IN DIAGNOSTICS AND DRUG DISCOVERY PROCESSES TO ENHANCE MARKET GROWTH 95
8.3 GENE EDITING 96
8.3.1 TO HELP IMPROVE GENE EDITING FUNCTIONS AND REDUCE TIME AND COSTS 96
8.4 CLINICAL WORKFLOW 98
8.4.1 TO HELP INCREASE EFFICIENCY OF CLINICAL WORKFLOWS 98
8.5 PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE 99
8.5.1 AI IN GENOMICS TO PREDICT OUTCOMES AND RISKS ASSOCIATED WITH CURING GENETIC DISEASES BASED ON AVAILABLE DATA 99
9 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION 101
9.1 INTRODUCTION 102
9.2 DIAGNOSTICS 103
9.2.1 AI IN GENOMICS FOR DIAGNOSTICS TO HELP IDENTIFY CHROMOSOMAL DISORDERS, DYSMORPHIC SYNDROMES, TERATOGENIC DISORDERS, AND SINGLE-GENE DISORDERS 103
9.3 DRUG DISCOVERY & DEVELOPMENT 105
9.3.1 GROWING APPLICATION OF AI IN GENOMICS IN DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET 105
9.4 PRECISION MEDICINE 107
9.4.1 FOCUSE ON IDENTIFYING EFFECTIVE MEDICAL TREATMENTS FOR PATIENTS TO DRIVE MARKET 107
9.5 AGRICULTURE & ANIMAL RESEARCH 109
9.5.1 AI IN GENOMICS TO HELP IMPROVE CROP AND LIVESTOCK PRODUCTIVITY 109
9.6 OTHER APPLICATIONS 111
10 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER 113
10.1 INTRODUCTION 114
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 115
10.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND COSTS OF DRUG DEVELOPMENT 115
10.3 RESEARCH CENTERS, ACADEMIC INSTITUTES, AND GOVERNMENT ORGANIZATIONS 117
10.3.1 INCREASED RESEARCH ACTIVITIES TO ENCOURAGE USE OF AI IN GENOMICS IN ACADEMIC AND GOVERNMENT INSTITUTES 117
10.4 HOSPITALS & HEALTHCARE PROVIDERS 118
10.4.1 GROWING DEMAND FOR PHARMACOGENOMICS TO PROPEL ACCEPTANCE OF NGS IN HOSPITALS 118
10.5 OTHER END USERS 120
11 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION 122
11.1 INTRODUCTION 123
11.2 NORTH AMERICA 124
11.2.1 NORTH AMERICA: RECESSION IMPACT 124
11.2.2 US 128
- 11.2.2.1 Initiatives to accelerate genomic research and growing adoption of AI to bolster market 128
11.2.3 CANADA 132
- 11.2.3.1 Increasing research in genomics to drive market 132
11.3 EUROPE 135
11.3.1 EUROPE: RECESSION IMPACT 135
11.3.2 UK 138
- 11.3.2.1 Adoption of AI in genomics for drug discovery to fuel market 138
11.3.3 GERMANY 142
- 11.3.3.1 Availability of funding for AI initiatives to boost market 142
11.3.4 FRANCE 145
- 11.3.4.1 Increasing government investments in NGS to boost market 145
11.3.5 REST OF EUROPE 148
11.4 ASIA PACIFIC 151
11.4.1 ASIA PACIFIC: RECESSION IMPACT 152
11.5 REST OF THE WORLD 156
11.5.1 REST OF THE WORLD: RECESSION IMPACT 157
12 COMPETITIVE LANDSCAPE 161
12.1 OVERVIEW 161
12.2 KEY MARKET PLAYERS’ STRATEGIES/RIGHT TO WIN 161
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS, 2022 164
12.4 MARKET RANKING ANALYSIS, 2022 164
12.5 COMPETITIVE BENCHMARKING 167
12.6 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS 171
12.6.1 STARS 171
12.6.2 PERVASIVE PLAYERS 171
12.6.3 EMERGING LEADERS 171
12.6.4 PARTICIPANTS 171
12.7 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES 173
12.7.1 PROGRESSIVE COMPANIES 173
12.7.2 DYNAMIC COMPANIES 173
12.7.3 RESPONSIVE COMPANIES 173
12.7.4 STARTING BLOCKS 173
12.8 COMPETITIVE SCENARIOS AND TRENDS 175
12.8.1 PRODUCT LAUNCHES/ENHANCEMENTS 175
12.8.2 DEALS 176
12.8.3 OTHER DEVELOPMENTS 178
13 COMPANY PROFILES 179
13.1 KEY PLAYERS 179
13.1.1 NVIDIA CORPORATION 179
13.1.2 MICROSOFT CORPORATION 184
13.1.3 GOOGLE, INC 189
13.1.4 INTEL CORPORATION 193
13.1.5 BENEVOLENTAI 198
13.1.6 SOPHIA GENETICS 201
13.1.7 ILLUMINA, INC 205
13.1.8 PREDICTIVE ONCOLOGY, INC 210
13.1.9 INVITAE CORPORATION 213
13.1.10 DEEP GENOMICS, INC 216
13.1.11 FABRIC GENOMICS, INC 218
13.1.12 VERGE GENOMICS 220
13.1.13 FREENOME HOLDINGS, INC 222
13.1.14 MOLECULARMATCH, INC 224
13.1.15 DANTE LABS 225
13.1.16 DATA4CURE 228
13.1.17 PRECISIONLIFE LTD 229
13.1.18 GENOOX 231
13.1.19 LIFEBIT 233
13.2 OTHER EMERGING PLAYERS 236
13.2.1 FDNA, INC 236
13.2.2 DNANEXUS 236
13.2.3 ENGINE BIOSCIENCES 237
13.2.4 TEMPUS LABS, INC 237
13.2.5 CONGENICA LTD 238
13.2.6 EMEDGENE, INC 238
13.2.7 SERAGON PHARMACEUTICALS, INC 239
14 APPENDIX 240
14.1 DISCUSSION GUIDE 240
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 245
14.3 CUSTOMIZATION OPTIONS 247
14.4 RELATED REPORTS 248
14.5 AUTHOR DETAILS 249
TABLE 1 CURRENCY CONVERSION RATES TABLE 2 FACTOR ANALYSIS TABLE 3 LIMITATIONS AND ASSOCIATED RISKS TABLE 4 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 5 SOFTWARE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 6 SOFTWARE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 7 SOFTWARE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 8 SERVICES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 9 SERVICES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 10 SERVICES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 11 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 12 MACHINE LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 13 MACHINE LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 14 MACHINE LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 15 MACHINE LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 16 DEEP LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 17 DEEP LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 18 DEEP LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 19 SUPERVISED LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 20 SUPERVISED LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 21 SUPERVISED LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 22 REINFORCEMENT LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 23 REINFORCEMENT LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 24 REINFORCEMENT LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 25 UNSUPERVISED LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 26 UNSUPERVISED LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 27 UNSUPERVISED LEARNING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 28 OTHER MACHINE LEARNING TECHNOLOGIES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 29 OTHER MACHINE LEARNING TECHNOLOGIES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 30 OTHER MACHINE LEARNING TECHNOLOGIES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 31 OTHER TECHNOLOGIES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 32 OTHER TECHNOLOGIES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 33 OTHER TECHNOLOGIES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 34 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION) TABLE 35 GENOME SEQUENCING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 36 GENOME SEQUENCING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 37 GENOME SEQUENCING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 38 GENE EDITING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 39 GENE EDITING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 40 GENE EDITING: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 41 CLINICAL WORKFLOW: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 42 CLINICAL WORKFLOW: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 43 CLINICAL WORKFLOW: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 44 PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 45 PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 46 PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 47 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 48 INDICATIVE LIST OF DEVELOPMENTS FOR DIAGNOSTICS APPLICATION TABLE 49 DIAGNOSTICS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 50 DIAGNOSTICS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 51 DIAGNOSTICS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 52 INDICATIVE LIST OF DEVELOPMENTS FOR DRUG DELIVERY & DISCOVERY APPLICATION TABLE 53 DRUG DISCOVERY & DEVELOPMENT: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 54 DRUG DISCOVERY & DEVELOPMENT: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 55 DRUG DISCOVERY & DEVELOPMENT: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 56 INDICATIVE LIST OF DEVELOPMENTS FOR PRECISION MEDICINE APPLICATION TABLE 57 PRECISION MEDICINE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 58 PRECISION MEDICINE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 59 PRECISION MEDICINE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 60 AGRICULTURE & ANIMAL RESEARCH: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 61 AGRICULTURE & ANIMAL RESEARCH: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 62 AGRICULTURE & ANIMAL RESEARCH: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 63 OTHER APPLICATIONS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 64 OTHER APPLICATIONS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 65 OTHER APPLICATIONS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 66 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 67 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES: INDICATIVE DEVELOPMENTS TABLE 68 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 69 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 70 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 71 RESEARCH CENTERS, ACADEMIC INSTITUTES, AND GOVERNMENT ORGANIZATIONS: INDICATIVE DEVELOPMENTS TABLE 72 RESEARCH CENTERS, ACADEMIC INSTITUTES, AND GOVERNMENT ORGANIZATIONS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 73 RESEARCH CENTERS, ACADEMIC INSTITUTES, AND GOVERNMENT ORGANIZATIONS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 74 RESEARCH CENTERS, ACADEMIC INSTITUTES, AND GOVERNMENT ORGANIZATIONS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 75 HOSPITALS & HEALTHCARE PROVIDERS: INDICATIVE DEVELOPMENTS TABLE 76 HOSPITALS & HEALTHCARE PROVIDERS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 77 HOSPITALS & HEALTHCARE PROVIDERS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 78 HOSPITALS & HEALTHCARE PROVIDERS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 79 OTHER END USERS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 80 OTHER END USERS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN NORTH AMERICA, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 81 OTHER END USERS: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET IN EUROPE, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 82 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 83 NORTH AMERICA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 84 NORTH AMERICA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 85 NORTH AMERICA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 86 NORTH AMERICA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 87 NORTH AMERICA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION) TABLE 88 NORTH AMERICA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 89 NORTH AMERICA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 90 US: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 91 US: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 92 US: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 93 US: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION) TABLE 94 US: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 95 US: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 96 CANADA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 97 CANADA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 98 CANADA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 99 CANADA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION) TABLE 100 CANADA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 101 CANADA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 102 EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 103 EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 104 EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 105 EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 106 EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION) TABLE 107 EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 108 EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 109 UK: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 110 UK: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 111 UK: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 112 UK: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION) TABLE 113 UK: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 114 UK: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 115 GERMANY: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 116 GERMANY: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 117 GERMANY: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 118 GERMANY: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION) TABLE 119 GERMANY: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 120 GERMANY: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 121 FRANCE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 122 FRANCE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 123 FRANCE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 124 FRANCE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION) TABLE 125 FRANCE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 126 FRANCE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 127 REST OF EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 128 REST OF EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 129 REST OF EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 130 REST OF EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION) TABLE 131 REST OF EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 132 REST OF EUROPE: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 133 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 134 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 135 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 136 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION) TABLE 137 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 138 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 139 REST OF THE WORLD: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING, 2021-2028 (USD MILLION) TABLE 140 REST OF THE WORLD: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION) TABLE 141 REST OF THE WORLD: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FOR MACHINE LEARNING, BY TYPE, 2021-2028 (USD MILLION) TABLE 142 REST OF THE WORLD: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY, 2021-2028 (USD MILLION) TABLE 143 REST OF THE WORLD: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 144 REST OF THE WORLD: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION) TABLE 145 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET TABLE 146 COMPANY FOOTPRINT ANALYSIS TABLE 147 PRODUCT FOOTPRINT ANALYSIS (26 COMPANIES) TABLE 148 FUNCTIONALITY FOOTPRINT ANALYSIS (26 COMPANIES) TABLE 149 REGIONAL FOOTPRINT ANALYSIS (26 COMPANIES) TABLE 150 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET: PRODUCT LAUNCHES/ENHANCEMENTS, 2020-2023 TABLE 151 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET: DEALS, 2020-2023 TABLE 152 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET: OTHER DEVELOPMENTS, 2020-2023 TABLE 153 NVIDIA CORPORATION: COMPANY OVERVIEW TABLE 154 NVIDIA CORPORATION: PRODUCTS/SERVICES OFFERED TABLE 155 NVIDIA CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS TABLE 156 NVIDIA CORPORATION: DEALS TABLE 157 MICROSOFT CORPORATION: COMPANY OVERVIEW TABLE 158 MICROSOFT CORPORATION: PRODUCTS/SERVICES OFFERED TABLE 159 MICROSOFT CORPORATION: DEALS TABLE 160 GOOGLE, INC.: COMPANY OVERVIEW TABLE 161 GOOGLE, INC.: PRODUCTS/SERVICES OFFERED TABLE 162 GOOGLE, INC.: PRODUCT LAUNCHES/ENHANCEMENTS TABLE 163 GOOGLE, INC.: DEALS TABLE 164 INTEL CORPORATION: COMPANY OVERVIEW TABLE 165 INTEL CORPORATION: PRODUCTS/SERVICES OFFERED TABLE 166 INTEL CORPORATION: PRODUCT LAUNCHES/ENHANCEMENTS TABLE 167 INTEL CORPORATION: DEALS TABLE 168 BENEVOLENTAI: COMPANY OVERVIEW TABLE 169 BENEVOLENTAI: PRODUCTS/SERVICES OFFERED TABLE 170 BENEVOLENTAI: DEALS TABLE 171 SOPHIA GENETICS: COMPANY OVERVIEW TABLE 172 SOPHIA GENETICS: PRODUCTS/SERVICES OFFERED TABLE 173 SOPHIA GENOMICS: DEALS TABLE 174 SOPHIA GENETICS: OTHERS TABLE 175 ILLUMINA, INC.: COMPANY OVERVIEW TABLE 176 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED TABLE 177 ILLUMINA, INC.: PRODUCT LAUNCHES/ENHANCEMENTS TABLE 178 ILLUMINA, INC.: DEALS TABLE 179 PREDICTIVE ONCOLOGY, INC.: COMPANY OVERVIEW TABLE 180 PREDICTIVE ONCOLOGY, INC.: PRODUCTS/SERVICES OFFERED TABLE 181 PREDICTIVE ONCOLOGY, INC.: DEALS TABLE 182 INVITAE CORPORATION: COMPANY OVERVIEW TABLE 183 INVITAE CORPORATION: PRODUCTS/SERVICES OFFERED TABLE 184 DEEP GENOMICS, INC.: COMPANY OVERVIEW TABLE 185 DEEP GENOMICS, INC.: PRODUCTS/SERVICES OFFERED TABLE 186 DEEP GENOMICS, INC.: DEALS TABLE 187 DEEP GENOMICS, INC.: OTHERS TABLE 188 FABRIC GENOMICS, INC.: COMPANY OVERVIEW TABLE 189 FABRIC GENOMICS, INC.: PRODUCTS/SERVICES OFFERED TABLE 190 FABRIC GENOMICS, INC.: PRODUCT LAUNCHES/ENHANCEMENTS TABLE 191 FABRIC GENOMICS, INC.: DEALS TABLE 192 VERGE GENOMICS: COMPANY OVERVIEW TABLE 193 VERGE GENOMICS: PRODUCTS/SERVICES OFFERED TABLE 194 VERGE GENOMICS: DEALS TABLE 195 FREENOME HOLDINGS, INC.: COMPANY OVERVIEW TABLE 196 FREENOME HOLDINGS, INC.: PRODUCTS/SERVICES OFFERED TABLE 197 FREENOME HOLDINGS, INC.: DEALS TABLE 198 MOLECULARMATCH, INC.: COMPANY OVERVIEW TABLE 199 MOLECULARMATCH, INC.: PRODUCTS/SERVICES OFFERED TABLE 200 DANTE LABS: COMPANY OVERVIEW TABLE 201 DANTE LABS: PRODUCTS/SERVICES OFFERED TABLE 202 DANTE LABS: PRODUCT LAUNCHES/ENHANCEMENTS TABLE 203 DANTE LABS: DEALS TABLE 204 DATA4CURE: COMPANY OVERVIEW TABLE 205 DATA4CURE: PRODUCTS/SERVICES OFFERED TABLE 206 PRECISIONLIFE LTD: COMPANY OVERVIEW TABLE 207 PRECISIONLIFE LTD: PRODUCTS/SERVICES OFFERED TABLE 208 PRECISIONLIFE LTD: DEALS TABLE 209 GENOOX: COMPANY OVERVIEW TABLE 210 GENOOX: PRODUCTS/SERVICES OFFERED TABLE 211 GENOOX: DEALS TABLE 212 LIFEBIT: COMPANY OVERVIEW TABLE 213 LIFEBIT: PRODUCTS/SERVICES OFFERED TABLE 214 LIFEBIT: DEALS TABLE 215 LIFEBIT: OTHERS
FIGURE 1 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET SEGMENTATION FIGURE 2 RESEARCH DESIGN FIGURE 3 RESEARCH APPROACH FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION FIGURE 6 KEY METRICS FOR ASSESSING SUPPLY OF ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FIGURE 7 REVENUES GENERATED BY COMPANIES FROM SALE OF ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS SOLUTIONS FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION FIGURE 9 BOTTOM-UP APPROACH FIGURE 10 ESTIMATION OF ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET SIZE BASED ON ADOPTION FIGURE 11 TOP-DOWN APPROACH FIGURE 12 DATA TRIANGULATION METHODOLOGY FIGURE 13 ASSUMPTIONS FOR RESEARCH STUDY FIGURE 14 SOFTWARE SEGMENT TO LEAD ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY OFFERING FIGURE 15 MACHINE LEARNING CONTINUES TO ACQUIRE LARGEST SIZE OF ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY TECHNOLOGY FIGURE 16 DEEP LEARNING TO BE FASTEST-GROWING SEGMENT OF ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET FOR MACHINE LEARNING FIGURE 17 GENOME SEQUENCING TO REGISTER HIGHEST CAGR IN ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY FUNCTIONALITY FIGURE 18 DIAGNOSTICS TO DOMINATE ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY APPLICATION FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO SECURE LEADING POSITION IN ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY END USER FIGURE 20 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET, BY REGION FIGURE 21 INCREASING ADOPTION OF ARTIFICIAL INTELLIGENCE (AI) SOLUTIONS FOR DRUG DISCOVERY & DEVELOPMENT AND PRECISION MEDICINE TO DRIVE MARKET FIGURE 22 NORTH AMERICA TO DOMINATE ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET DURING FORECAST PERIOD FIGURE 23 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES AND US DOMINATED MARKET IN NORTH AMERICA IN 2022 FIGURE 24 SOFTWARE SEGMENT TO HOLD MAJORITY MARKET SHARE IN 2028 FIGURE 25 MACHINE LEARNING TO SURPASS OTHER TECHNOLOGIES IN 2028 FIGURE 26 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2028 FIGURE 27 GENOME SEQUENCING TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD FIGURE 28 DIAGNOSTICS TO DOMINATE MARKET IN 2028 FIGURE 29 COST OF GENOME ANALYSIS VS. LEVELS OF RAW DATA GENERATED, 2003-2023 FIGURE 30 HEALTHCARE BREACHES REPORTED TO US DEPARTMENT OF HEALTH AND HUMAN SERVICES, 2019-2021 FIGURE 31 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET: ECOSYSTEM ANALYSIS FIGURE 32 SOFTWARE SEGMENT ACCOUNTED FOR LARGER MARKET SHARE IN 2022 FIGURE 33 MACHINE LEARNING SEGMENT ACCOUNTED FOR LARGER MARKET SHARE IN 2022 FIGURE 34 DEEP LEARNING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 35 GENOME SEQUENCING SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 36 DIAGNOSTICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 37 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 38 ASIA PACIFIC TO EMERGE AS NEW HOTSPOT DURING FORECAST PERIOD FIGURE 39 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 FIGURE 40 NORTH AMERICA: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET SNAPSHOT FIGURE 41 ASIA PACIFIC: ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET SNAPSHOT FIGURE 42 KEY DEVELOPMENTS BY MAJOR MARKET PLAYERS BETWEEN JANUARY 2020 AND MARCH 2023 FIGURE 43 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS, 2022 FIGURE 44 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET SHARE ANALYSIS, 2022 FIGURE 45 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2022 FIGURE 46 ARTIFICIAL INTELLIGENCE (AI) IN GENOMICS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2022 FIGURE 47 NVIDIA CORPORATION: COMPANY SNAPSHOT FIGURE 48 MICROSOFT CORPORATION: COMPANY SNAPSHOT FIGURE 49 GOOGLE, INC.: COMPANY SNAPSHOT, 2022 FIGURE 50 INTEL CORPORATION: COMPANY SNAPSHOT FIGURE 51 BENEVOLENTAI: COMPANY SNAPSHOT FIGURE 52 SOPHIA GENETICS: COMPANY SNAPSHOT FIGURE 53 ILLUMINA, INC.: COMPANY SNAPSHOT FIGURE 54 PREDICTIVE ONCOLOGY, INC.: COMPANY SNAPSHOT FIGURE 55 INVITAE CORPORATION: COMPANY SNAPSHOT, 2022
